Novonix (NVNXF) Equity Average (2021 - 2025)

Novonix has reported Equity Average for 4 years, with the latest figure at $164.3 million in Q4 2025.

• For the quarter ending Q4 2025, Equity Average changed N/A year-over-year to $164.3 million; the trailing twelve-month figure through Dec 2025 stood at $164.3 million (changed N/A YoY), and the FY2025 full-year result was $149.6 million, down 6.92% from the prior year.
• Equity Average for Q4 2025 stood at $164.3 million, up from $152.3 million in the prior quarter.
• The five-year high for Equity Average was $243.5 million in Q4 2022, with the low at $93.3 million in Q2 2021.
• Historically, Equity Average has averaged $165.8 million across 4 years, with a median of $162.2 million in 2023.
• The largest YoY upside for Equity Average was 34.25% in 2023 against a maximum downside of 34.25% in 2023.
• Novonix's Equity Average stood at $93.3 million in 2021, then surged by 161.11% to $243.5 million in 2022, then slumped by 34.25% to $160.1 million in 2023, then climbed by 2.63% to $164.3 million in 2025.
• The last three Equity Average figures came in at $164.3 million (Q4 2025), $152.3 million (Q2 2025), and $160.1 million (Q4 2023), per Business Quant data.